Matt Kaufman’s Post

Midweek Matters Did you know? Researchers from the University of California, Irvine (UCI) conducted a study in which older adults were exposed to a fragrance in their bedrooms for two hours every night for six months. The participants experienced a remarkable 226% increase in cognitive capacity compared to a control group, as measured by a word list memory test. The fragrant exposure improved the integrity of a brain pathway called the left uncinate fasciculus, which connects the medial temporal lobe to the prefrontal cortex and tends to weaken with age. This non-invasive technique suggests that the sense of smell may be harnessed to enhance memory and potentially mitigate dementia risks, building on previous knowledge linking olfactory loss to neurological diseases. Read more... Thanks to John Fry for sharing the read. #nextlevelthinking #olfaction #neuromarketing #sensorymarketing #memorydesign #focusboost https://lnkd.in/gvbQWejN

How do scents can boost brain memory ? Find out in this interesting study. #memory #brain #cognitive #smells #scents #senior

Check out today’s collection of captivating articles that dive into the complexities of the human brain and body. *Please note: These articles are shared for informational purposes only. The first article centers on the goal to heal those with mental disorders using brain implants. The technique is called deep brain stimulation and operates from the idea that electrical stimulation can reset brains that are laden with depression, obsessive-compulsive disorder and post-traumatic stress disorder, and other psychiatric disorders. Several people in the United States have entered clinical trials involving this technique, hoping the treatment can help ease their symptoms. As mentioned, an estimated 280 million people worldwide have been diagnosed with major depression, with 2.8 million of those people in the United States. https://lnkd.in/gwXWfisp   Is it possible we’re made of mathematics? The next article states researchers have determined that men are composed of about 36 trillion cells, while women have some 28 trillion cells, and a 10-year-old child has roughly 17 trillion cells. New data reveals that if a human’s cells of similar sizes are grouped together, each group contributes about the same total amount of mass to the body, and the amount of matter that makes up cells in each size category is largely constant. Having such information could be vital to better understanding diseases. https://lnkd.in/e8AxGfcv   The third article highlights a new type of brain cell. It states there are two types of brain cell categories: neurons and glia. For many years, it has been believed that it is primarily neurons which use synaptic transmission that releases neurotransmitters to communicate with other cells. But, using two-photon imaging, Andrea Volterra and her team in Switzerland, have seemingly confirmed that glia cells have the same ability needed for synaptic transmission. As mentioned, more insight into these cells could lead to better treatment for Parkinson’s diseases and other conditions. https://lnkd.in/g7f97Dyh #manhattanlife #healthnews #healthtech #healthtechnology #healthinnovation #health

Depression relief at the drop of a hat? Motif Neurotech's “pea-sized” Digitally programmable Over-brain Therapeutic (DOT) is minimally invasive, requires 20 minutes to implant and can be activated at home with a wearable to “lift the fog” for people with depression. Jacob Robinson, Motif’s CEO, envisions that mental health issues in the future will be treated much like heart disease today with a combination of drugs and devices, using data from brain-computer interfaces and continuous monitoring to identify key biomarkers that enable psychiatrists to head off mental health crises. Learn more: https://ow.ly/AUZe50RNH1S #MentalHealthTech #BrainHealth #DepressionTreatment #WearableTech #Neuroscience #MentalWellness #TechForGood

Right on cue, the press is responding to President Biden’s manifest mental lapses by rolling out the so-called experts. “Neurologists say blanking on the names of acquaintances or having difficulty remembering dates from the past, especially when under stress, can simply be part of normal aging,” said a recent NBC News report. Such pieces typically note that only a medical doctor can diagnose cognitive impairment and dementia. That’s true, but it’s also true that dementia and mild cognitive impairment are hugely underdiagnosed. One study found a nondiagnosis rate of more than 90% for mild cognitive impairment, suggesting 7.4 million Americans unknowingly live with that condition. That’s partially because the cognitive tests doctors use to diagnose these conditions miss many cases. Many older people also don’t get tested because they consider their failing memories to be a normal part of aging or stress. But diagnostic tests now in development could determine whether someone is mentally impaired simply based on how he speaks or walks, or even with a self-administered blood test. Studies have found that gaits can start to slow more than a decade before patients are diagnosed with dementia. Those with different forms of dementia also exhibit different gait abnormalities. Gait rhythm has been correlated with mental processing speeds. Even subtle change in the brain can affect the way people walk. One study found that those with a frontal gait disorder—short, shuffling steps—are more than four times as likely to develop vascular dementia. By using machine learning, scientists have developed a wearable technology that can identify Alzheimer’s and Lewy Body disease merely based on the way someone walks. Artificial intelligence is also enabling scientists to analyze voice recordings to detect patterns in patients with early cognitive impairment. These models have found that people with dementia, even in its early stages, speak with different pitches, volume, cadences and intonations than elderly people who are cognitively normal. A study last year presented at the Alzheimer’s Association International Conference found that a blood test measuring specific biomarkers correctly identified Alzheimer’s in approximately 85% of cases later diagnosed by specialists. By comparison, primary-care doctors using cognitive tests and brain scans accurately diagnosed only 55% of cases. Scientists also found that such biomarkers could be isolated with merely a finger-prick of blood, creating the possibility that such tests could be administered at home. Artificial intelligence is even enabling blood tests that can predict whether a patient will develop dementia a decade later. A study that used blood samples from more than 50,000 people in the U.K. found four proteins were associated with the subsequent development of different types of dementia over 14 years.

In today's fast-paced world, maintaining optimal #mentalhealth is critical to success and overall well-being. However, many men suffer from a puzzling condition known as "brain fog." Brain fog, a term commonly used to describe a sense of mental confusion, lack of focus, and impaired cognitive function, is a phenomenon that affects individuals across various age groups. In fact, one of the symptoms of low testosterone in men is brain fog. In recent years, researchers have investigated the relationship between testosterone levels and cognitive performance, which has led to the development of Testosterone Replacement Therapy (#TRT) as a viable remedy. https://lnkd.in/eiuwxb23 #mensmentalhealth

Must read alert 📖👀🚨 To preserve your cognition as long as possible and get the best care for your loved ones, this blog post from CEO Elli Kaplan is required reading. What are the brain health secrets she’d like everyone to know? Here’s an important one, “Cognitive screening doesn’t happen routinely!” Click to learn the rest… #Alzheimers #BrainHealth

𝐂𝐨𝐠𝐧𝐢𝐭𝐢𝐯𝐞 𝐀𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐓𝐫𝐚𝐢𝐧𝐢𝐧𝐠 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: 𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 :– https://lnkd.in/dfFD2taT (𝙐𝙨𝙚 𝘾𝙤𝙧𝙥𝙤𝙧𝙖𝙩𝙚 𝙈𝙖𝙞𝙡 𝙄𝘿 𝙛𝙤𝙧 𝙏𝙤𝙥 𝙋𝙧𝙞𝙤𝙧𝙞𝙩𝙮) This report describes the global market size of #Cognitive_Assessment_and_Training_in_Healthcarefrom 2019 to 2022 and its CAGR from 2019 to 2023, and also #forecasts its market #size to the end of 2031 and its expected to #grow with a #CAGR of 31% from 2024 to 2031. Cognitive assessment and training in healthcare refer to the systematic evaluation and enhancement of cognitive functions such as memory, attention, problem-solving, and executive functions. These practices are essential in diagnosing cognitive impairments, planning interventions, and promoting cognitive health in various populations, including children, adults, and the elderly. By Application : ·        Brain Training ·        Academic Research ·        Clinical Trial ·        Screening & Diagnostics ·        Others By Company : Cambridge Cognition, CogniFit, Cogstate, Brain Resource Center , WIRB-Copernicus Group, Quest Diagnostics, Signant Health, BrainHQ from Posit Science, Clario, Cognetivity Neurosciences Ltd. #CognitiveAssessment #CognitiveTraining #BrainHealth #Neuropsychology #MentalHealth #DementiaCare #CognitiveRehabilitation #HealthcareInnovation #AgingPopulation #PersonalizedMedicine #CambridgeCognitionLtd #CogniFitInc #CogstateLtd #BrainResourceCompany #WIRBCopernicusGroup #QuestDiagnosticsIncorporated #SignantHealth #PositScience #Clario #CognetivityNeurosciences #Healthcare #Neurology #BrainHealth #MentalFitness #Dementia #Alzheimers #PatientCare #snr #statsandresearch

📣 Time for change 📣 “More than 50,000 human-brain-imaging articles have been published since MRI came on the scene in the 1990s. But of those, less than 0.5% consider health factors specific to women. Women’s health is both understudied and underfunded. This oversight is especially troubling given that 70% of people with Alzheimer’s and 65% of those with depression are women. Some neurological conditions are experienced only by people who have menstrual periods: postpartum depression, perimenopausal ‘brain fog’, endometriosis and menstrual migraines, to name a few… Representation is not the problem: about 50% of people enrolled in neuroimaging studies listed on OpenNeuro.org are women. Researchers are simply not choosing to study (and funders to invest in the study of) health factors specific to women, which is perhaps not surprising when 80% of tenured neuroscientists are men.”